The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi

Documenti analoghi

• Evaluation of NAD(H) analogues as selective inhibitors for Trypanosoma cruzi S-Adenosylhomocysteine hydrolase
  di: Li, Qing-Shan, et al.
  Pubblicazione: (2009)
• The Rationale for Targeting the NAD/NADH Cofactor Binding Site of Parasitic S-Adenosyl-L-homocysteine Hydrolase for the Design of Anti-parasitic Drugs
  di: Cai, Sumin, et al.
  Pubblicazione: (2009)
• Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 3. The role of lysyl and tyrosyl residues of the C-terminal extension
  di: Cai, Sumin, et al.
  Pubblicazione: (2010)
• Characterization of human S-adenosyl-homocysteine hydrolase in vitro and identification of its potential inhibitors
  di: Hao, Weiwei, et al.
  Pubblicazione: (2017)
• Crystallization of mouse S-adenosyl-l-homocysteine hydrolase
  di: Ishihara, Masaaki, et al.
  Pubblicazione: (2010)